Evaluation: Healthcare AI must surpass accuracy metrics to establish clinical validity, safety, and suitability for diverse ...
Launching next year, the new CMS Innovation Center initiative—known as the GENEROUS Model—aims to align Medicaid drug prices ...
This episode of Pharma Pulse discusses FDA’s growing National Priority Voucher initiative, fresh data on oral semaglutide’s ...
Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...
Ultimately, Khan emphasized that protecting PHI requires more than compliance checkboxes—it demands a continuous, structured ...
Ho next-generation AI-driven traceability hubs can transform pharmaceutical serialization from a compliance requirement into a business advantage, while enabling real-time supply chain visibility, ...
Eli Lilly collaborates with the Trump administration to improve access to GLP-1 receptor agonists for millions of Americans, including those on government programs. The agreement allows Medicare ...
Pharma’s push into direct-to-patient sales is reshaping the front end of drug distribution, but wholesalers like Cencora, McKesson, and Cardinal Health remain indispensable as the backbone of the ...
Pharma has traditionally operated via a value chain that moved from manufacturer to wholesaler/distributor to pharmacy to patient, with reimbursement via the payer/pharmacy benefit manager (PBM).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback